Abstract
We prospectively evaluated the effects of L-carnitine supplementation on plasma free carnitine (FC) levels, serum lipid profile, and erythropoietin (rhEPO) requirement in 24 children treated with peritoneal dialysis (PD; n = 16) or hemodialysis (HD; n = 8). The study was divided into a 3-month observation period, and a 3-month treatment period during which patients received 20 mg/kg per day of L-carnitine given orally. Clinical, biochemical, and hematological data were collected every 3 months. FC levels were measured in plasma and peritoneal dialysate by tandem mass spectrometry. There were no statistically significant changes in lipid levels, hemoglobin, or rhEPO requirements during the course of the study. Fifteen patients (13 PD, 2 HD) had plasma FC levels measured before and after treatment; FC levels increased from 32.1 ± 14.1 μmol/l to 80.9 ± 38.7 μmol/l (P < 0.001). In PD patients, dialysate FC losses increased from 106 ± 78 μmol/day at baseline to 178 ± 119 μmol/day after supplementation. Positive correlations between FC plasma levels and dialysate levels (R = 0.507) or daily excretion (R = 0.603) were found after treatment. In our case series, an oral dose of 20 mg/kg per day of L-carnitine restored FC levels and produced a positive carnitine balance with no significant effects on hematological parameters or lipid profile over a 3-month period. Prolonged treatment duration may be required to obtain significant results.
Similar content being viewed by others
References
Guarnieri G, Situlin R, Biolo G (2001) Carnitine metabolism in uremia. Am J Kidney Dis 38:S63–S67
Hoppel C (2003) The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 41:S4–S12
Eknoyan G, Latos DL, Lindberg J (2003) Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis 41:868–876
Hurot JM, Cucherat M, Haugh M, Fouque D (2002) Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol 13:708–714
Winchester JF (2000) L-carnitine and peritoneal dialysis. Perit Dial Int 20:S150–S153
National Kidney Foundation (2000) K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:S54–S55
Schröder CH (2003) The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 18:805–809
Schreiber BD (2006) Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients. Blood Purif 24:128–139
Belay B, Esteban-Cruciani N, Walsh CA, Kaskel FJ (2006) The use of levo-carnitine in children with renal disease: a review and a call for future studies. Pediatr Nephrol 21:308–317
Warady BA, Borum P, Stall C, Millspaugh J, Taggart E, Lum G (1990) Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 10:109–114
Kosan C, Sever L, Arisoy N, Cahskan S, Kasapcopur O (2003) Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:1184–1188
Lilien MR, Duran M, Quark JME, Frankuisen JJ, Schröder CH (2000) Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis. Pediatr Nephrol 15:17–20
Murakomi R, Momota T, Yoshiya K, Yoshikawa N, Nakamura H, Honda M, Ito H (1990) Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis. J Pediatr Gastroenterol Nutr 11:371–374
Zachwieja J, Duran M, Joles JA, Allers PJ, van de Hurk D, Frankhuisen JJ, Donckerwolcke RA (1994) Amino acid and carnitine supplementation in haemodialysed children. Pediatr Nephrol 8:739–743
Soldin OP, Bierbower LH, Chai JJ, Choi JJ, Thompson-Hoffmann S, Soldin SJ (2004) Serum iron, ferritin, total iron binding capacity, hs-CRP, LDL cholesterol and magnesium in children; new reference intervals using the Dade Dimension Clinical Chemistry System. Clin Chim Acta 342:211–217
Centers for Medicare & Medicaid Services (2002) Levocarnitine for use in the treatment of carnitine deficiency in ESRD patients. Transmittal AB-02-165. Baltimore: Department of Health and Human Services, Centers for Medicare & Medicaid Services. November
Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Horl WH, Kovarik J (1999) Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int 69:S93–S106
Constantin-Teodosiu D, Kirby DPJ, Short AH, Burden RP, Morgan AG, Greenhaff PL (1996) Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients. Kidney Int 49:158–162
Vacha GM, Giorcelli G, Siliprandi N, Corsi M (1983) Favorable effects of L-carnitine treatment on hypertrigliceridemia in hemodialysis patients. Decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 38:532–540
Berard E, Iordache A (1992) Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: about two cases. Nephron 62:368–369
KDOQI; National Kidney Foundation (2006) III. Clinical practice recommendations for anemia in chronic kidney disease in children. Am J Kidney Dis 47(Suppl 3):S86–S108
Mir S, Kantar M, Yalaz M, Keskinoglu AI, Sil C, Huseyinov A (2002) Effect of hemodialysis on carnitine levels in children with chronic renal failure. Pediatr Int 44:70–73
Chatzdimitriou C, Pliakogiannis T, Evangeliou A, Tsalkidou T, Böhles HJ, Kalaitzidis K (1992) Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 13(Suppl 2):S444–S447
Acknowledgements
This study was supported by a grant from Sigma Tau, Italy. The authors wish to thank Dr. Anna Capurro for English revision and Mrs. Daniela Accerbis for manuscript preparation.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Verrina, E., Caruso, U., Calevo, M.G. et al. Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis. Pediatr Nephrol 22, 727–733 (2007). https://doi.org/10.1007/s00467-006-0408-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0408-8